Dogwood Therapeutics, Inc. , a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response.
Dogwood Therapeutics stock last closed at $5.48, up 1.29% from the previous day, and has decreased 51.5% in one year. It has overperformed other stocks in the Biotechnology industry by 0.25 percentage points. Dogwood Therapeutics stock is currently +238.27% from its 52-week low of $1.62, and -81.28% from its 52-week high of $29.28.
As of Apr 30, 2025, there are 1.91M shares of DWTX outstanding. The market cap of DWTX is $10.47M. In the past 24 hours, 139,412 DWTX shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy DWTX stock.
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected your brokerage, it's time to fill out some personal info so you are able to invest in DWTX stock today.
Now that you have filled out your info on our top ranked stock app, you can securely and quickly fund your account:
Check out the walkthrough below to see the process of transferring funds into your investment account.
Once you have identified the best place to buy Dogwood Therapeutics stock, it's absolutely critical to analyze their stock before you invest, so you truly comprehend the risk as well as the upside.
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on DWTX's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge DWTX's true value.
You can do additional valuation research on DWTX's stock here.
Out of 1 sell side analysts who give ratings on DWTX, the consensus analyst rating on DWTX is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Dogwood Therapeutics stock forecast page.
Over the last 12 months, executives and large shareholders at DWTX have not bought or sold any shares.
Research more about who owns DWTX stock here.
No, Dogwood Therapeutics doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two primary types of orders:
Hit the Open Trade button and eToro will place your order.
If you want more assistance investing in stocks on eToro, watch the helpful video below:
Now that you own some shares in DWTX, you'll want to keep up with your new shares.
Add DWTX to a watchlist to track the most important metrics related to your DWTX stock.
To summarize, here are the 6 steps to buy Dogwood Therapeutics stock:
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep track of your investment in Dogwood Therapeutics, get started below.